Exelixis - 53 Year Dividend History | EXEL
Historical dividend payout and yield for Exelixis (EXEL) since 1971. The current TTM dividend payout for Exelixis (EXEL) as of April 26, 2024 is $0.00. The current dividend yield for Exelixis as of April 26, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$6.937B |
$1.830B |
|
Exelixis, Inc. is an oncology-focused biotechnology company, which primarily focuses on the discovery, development and commercialization of new drugs for the treatment of difficult-to-treat cancers. The company has four approved drugs in its portfolio. Of these, two are derived from cabozantinib, the company's flagship molecule, which is an inhibitor of multiple tyrosine kinases, including MET, AXL, VEGF receptors and RET.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
